A company using image analysis and deep learning to discover therapies for diseases often considered difficult to treat is raising $123 million in new venture funds. . . . → Read More: A.I. Discovery Company Raises $123M in Venture Funds
|
|||||
|
       
  |
GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases. . . . → Read More: Start-Up to Engineer T-Cells for Autoimmune Diseases 
A new venture fund plans investments in early-stage life science companies addressing critical needs in therapeutics, but also agriculture and industrial biotechnology. . . . → Read More: Venture Fund Plans $350M for Biotech Start-Ups 
A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is raising $10 million in its first venture funding round. . . . → Read More: New Allergy Biotech Launches, Raises $10M 
A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds  Comments are closed  Finance, Intellectual property  biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, university, venture capital 
A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round. . . . → Read More: Synthetic Protein Maker Raises $91.3M in Venture Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, engineering, entrepreneurs, equity, Europe, genomics, investment, life sciences, mathematics, physical sciences, U.K., venture capital 
For the first half of 2020, venture investing declined compared to 2019, but life science and biotechnology investments continued growing for the year. . . . → Read More: Venture Funding Down in 2020, Life Sciences Stay Hot One comment - (Comments are closed) Finance biotechnology, Canada, economics, engineering, entrepreneurs, equity, investment, life sciences, statistics, venture capital 
A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells. . . . → Read More: Start-Up Developing Inside-Cell Delivery, Gains $28.5M Comments are closed Finance, Intellectual property biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, university, venture capital 
A new enterprise developing and manufacturing gene therapies, both its own and for others, is underway, raising $40 million in venture funds. . . . → Read More: Gene Therapy Production Company Opens, Raises $40M One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, pharmaceuticals, university, venture capital 
A foundation project identified its first five investment funds providing capital for start-up businesses founded by people usually overlooked by venture investors. . . . → Read More: Investment Funds Named for Underserved Entrepreneurs Comments are closed Finance economics, engineering, entrepreneurs, equity, investment, life sciences, manufacturing, mathematics, university, venture capital |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||